Clearside Biomedical, Inc. (NASDAQ:CLSD) Receives Consensus Rating of “Buy” from Analysts
Shares of Clearside Biomedical, Inc. (NASDAQ:CLSD – Get Free Report) have received a consensus rating of “Buy” from the five research firms that are covering the company, MarketBeat Ratings reports. Five research analysts have rated the stock with a buy rating. The average 1 year price objective among analysts that have issued a report on […]
Shares of Clearside Biomedical, Inc. (NASDAQ:CLSD – Get Free Report) have received a consensus rating of “Buy” from the five research firms that are covering the company, MarketBeat Ratings reports. Five research analysts have rated the stock with a buy rating. The average 1 year price objective among analysts that have issued a report on […]
